Liver Cirrhosis Market to Grow at a 4.36% CAGR Forecast to 2020

PUNE, INDIA, July 19, 2016 /EINPresswire.com/ --
About Cirrhosis of the Liver
Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.
Research analysts forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.

Complete report details @ https://www.wiseguyreports.com/reports/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F Hoffman La-Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck

Request a sample report @ https://www.wiseguyreports.com/sample-request/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Other prominent vendors
• Bristol-Myers Squibb
• Conatus Pharmaceuticals
• Gwo Xi Stem Cell Applied Technology
• Instituto Grifols
• Intercept Pharmaceuticals
• NGM Biopharmaceuticals
• Norgine
• Pharmicell
• Salix Pharmaceuticals
• Stempeutics Research
Market driver
• High prevalence of liver cirrhosis
• For a full, detailed list, view our report
Market challenge
• Adverse effects of drugs
• For a full, detailed list, view our report
Market trend
• Use of off-label drugs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Table of content
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Etiology
• Symptoms
• Pathophysiology
• Diagnosis
• Epidemiology
• Prevention
• Treatment
• Impact of alcohol consumption on liver cirrhosis
PART 06: Pipeline portfolio
• Information on pipeline candidates
• Clinical trials for liver cirrhosis
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 09: Market segmentation by types of liver cirrhosis
PART 10: Market segmentation by types of liver cirrhosis treatment
• Medications to treat causes of liver cirrhosis
• Medications to treat complications of liver cirrhosis
PART 11: Geographical segmentation
• Liver cirrhosis medication market in Americas
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in EMEA
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in APAC
• Market overview
• Market size and forecast
PART 12: Market drivers
• High prevalence of liver cirrhosis
• Advances in technology
• High unmet medical needs
• Changes in lifestyle
PART 13: Impact of drivers
PART 14: Market challenges
• Use of alternative therapies
• Adverse effects of drugs
• Poor patient adherence
• Stringent regulatory guidelines
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Rise in public awareness
• Increase in R&D
• Use of off-label drugs
• Patient assistance programs
PART 17: Vendor landscape
• Competitive scenario
• F Hoffmann-La Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=466167

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here